Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Medtronic
Boehringer Ingelheim
Moodys
Merck
Colorcon
McKesson

Last Updated: October 16, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Idebenone

See Plans and Pricing

« Back to Dashboard

Development status for investigational drug Idebenone: Sponsors, patents, clinical trial progress

Idebenone is an investigational drug.

There have been 25 clinical trials for Idebenone. The most recent clinical trial was a Phase 3 trial, which was initiated on May 1st 2016.

The most common disease conditions in clinical trials are Friedreich Ataxia, Cerebellar Ataxia, and Ataxia. The leading clinical trial sponsors are Santhera Pharmaceuticals, National Institute of Neurological Disorders and Stroke (NINDS), and Qilu Pharmaceutical Co., Ltd.

There are six hundred and forty-three US patents protecting this investigational drug and five international patents.

Recent Clinical Trials for Idebenone
TitleSponsorPhase
Idebenone Treatment of Early Parkinson's DiseasesymptomsQilu Pharmaceutical Co., Ltd.Phase 4
Idebenone Treatment of Early Parkinson's DiseasesymptomsSecond Affiliated Hospital of Soochow UniversityPhase 4
Phase III Study With Idebenone in Patients With Duchenne Muscular Dystrophy (SIDEROS-E)Santhera PharmaceuticalsPhase 3

See all Idebenone clinical trials

Clinical Trial Summary for Idebenone

Top disease conditions for Idebenone
Top clinical trial sponsors for Idebenone

See all Idebenone clinical trials

US Patents for Idebenone

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Idebenone   See Pricing Cellulose micropowder ASAHI KASEI KABUSHIKI KAISHA (Tokyo, JP)   See Pricing
Idebenone   See Pricing Composition for hot-melt extrusion and method for producing hot-melt extrusion product using same Shin-Etsu Chemical Co., Ltd. (Tokyo, JP)   See Pricing
Idebenone   See Pricing Deuterated idebenone Concert Pharmaceuticals, Inc. (Lexington, MA)   See Pricing
Idebenone   See Pricing Compositions and methods for improving human health and nutrition BiOWiSH Technologies, Inc. (Cincinnati, OH)   See Pricing
Idebenone   See Pricing Compounds which inhibit neuronal exocytosis LUBRIZOL ADVANCED MATERIALS, INC (Cleveland, OH)   See Pricing
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Idebenone

Drugname Country Document Number Estimated Expiration Related US Patent
Idebenone European Patent Office 3181616 2034-08-12   See Pricing
Idebenone Japan 6216074 2034-08-12   See Pricing
Idebenone Japan WO2016024493 2034-08-12   See Pricing
Idebenone Taiwan 201613646 2034-08-12   See Pricing
Idebenone Taiwan I572360 2034-08-12   See Pricing
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Colorcon
McKinsey
Express Scripts
McKesson
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.